in Air Transport

Royal Air Maroc and Gulf Air sign SPA agreement

Posted 22 January 2019 · Add Comment

Gulf Air and Royal Air Maroc recently signed a Special Prorate Agreement (SPA) effective from 22 January 2019.

 

The agreement builds upon the current travel opportunities for passengers of both airlines beyond the hubs of Bahrain International Airport and Casablanca Mohammed V International Airport.

This new SPA agreement supports facilitating travel for passengers of both airlines who wish to explore cities and regions that are not directly served by the home carrier – including domestic points in Morocco, West Europe and GCC.

* required field

Post a comment

Other Stories
Advertisement
Latest News

Tanzania welcomes tourists as Covid 19 numbers decline

The Tanzanian government has lifted the ban on scheduled and non-scheduled international air travel, following a decline in detected COVID-19 cases in the country.

A new life of lease?

One of the challenges for African airlines is gaining access to suitable aircraft. Now, as Victoria Moores reports, leasing-support company, Six West, has an idea that could help.

737 MAX production resumes

Boeing has resumed production of the 737 MAX at the company’s Renton, Wash. factory.

ICAO, ILO and IMO call for essential air and sea personnel 'key worker' designations

ICAO joined the International Labour Organization (ILO) and the International Maritime Organization (IMO) issued a Joint Statement to governments, on the need to ensure ‘key worker’ designations for the millions of skilled

Calls for South African government to support its aviation sector

The International Air Transport Association (IATA), the Airlines Association of Southern Africa (AASA) and the Board of Airline Representatives of South Africa (BARSA) are calling on the South African government to provide specific

Denel’s ventilator project reaches critical stages

South African aerospace and military technology company Denel has said two projects to design and manufacture local ventilators to be used for the treatment of Covid-19 patients have reached critical stages.

AVMENA20 SK14191020
See us at
AVMENA20 BT1309100620